Mount Yale Investment Advisors, LLC Xenon Pharmaceuticals Inc. Transaction History
Mount Yale Investment Advisors, LLC
- $1.21 Billion
- Q2 2025
A detailed history of Mount Yale Investment Advisors, LLC transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Mount Yale Investment Advisors, LLC holds 1,015 shares of XENE stock, worth $43,310. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,015Holding current value
$43,310% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding XENE
# of Institutions
222Shares Held
73.2MCall Options Held
336KPut Options Held
309K-
Avoro Capital Advisors LLC New York, NY5.4MShares$230 Million3.08% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.34MShares$185 Million1.31% of portfolio
-
Braidwell LP Stamford, CT3.61MShares$154 Million6.91% of portfolio
-
Janus Henderson Group PLC London, X03.58MShares$153 Million0.06% of portfolio
-
Capital International Investors Los Angeles, CA3.18MShares$136 Million0.02% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $2.66B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...